Table 1.
Gender | Age, years | Proteinuria, g/24 h | Pathological diagnosis | Serum creatine, µmol/L | BUN, mmol/L |
---|---|---|---|---|---|
Boy | 4.2 | 1.62 | MCD | 19 | 2.86 |
Boy | 4.8 | 1.43 | MCD | 21 | 3.22 |
Boy | 2.2 | 1.59 | MCD | 38 | 2.42 |
Boy | 3.9 | 0.14 | MCD | 26 | 5.01 |
Boy | 4.9 | 2.21 | MCD | 33 | 2.45 |
Boy | 4.2 | 0.02 | MCD | 28 | 409 |
Girl | 1.7 | 3.29 | FSGS | 21 | 2.53 |
Boy | 4.3 | 2.47 | FSGS | 33 | 6.99 |
Girl | 2.0 | 3.23 | FSGS | 27 | 5.21 |
Boy | 2.2 | 3.46 | FSGS | 21 | 6.07 |
Boy | 10.5 | 4.60 | FSGS | 28 | 7.24 |
Boy | 12.5 | 8.60 | FSGS | 27 | 5.10 |
Girl | 4.5 | 0.81 | FSGS | 525 | 24.32 |
Girl | 10.8 | 0.30 | MN | 38 | 3.60 |
Girl | 13.0 | 0.90 | MN | 35 | 2.92 |
Boy | 11.0 | 0.86 | MN | 41 | 2.85 |
Girl | 6.0 | 5.76 | MN | 35 | 5.60 |
Boy | 4.2 | 0.67 | MN | 26 | 2.14 |
MN, membrane nephropathy; MCD, minimal change disease; FSGS, focal segmental glomerulosclerosis.